Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)

NCT00703261 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Vascular Disease

Interventions

DRUG: atorvastatin
DRUG: placebo

Sponsor

Merck Sharp & Dohme LLC